Updated Jul 16, 2026
Lucera Erick has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $181K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-26 | DYN | Dyne Therapeutics, Inc. | S — Open-market sale | 2.4K | $20.37 | $48K |
| 2026-05-14 | DYN | Dyne Therapeutics, Inc. | S — Open-market sale | 1.4K | $18.36 | $27K |
| 2026-04-03 | DYN | Dyne Therapeutics, Inc. | S — Open-market sale [10b5-1] | 5.7K | $18.64 | $107K |
| 2026-02-17 | DYN | Dyne Therapeutics, Inc. | A — Grant or award | 65.0K | $0.00 |
Lucera Erick is a corporate insider — currently tracked as Insider of Dyne Therapeutics, Inc. (DYN). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($181K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lucera Erick profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.